WOUNDS







Press Release

Best in Class: Scottsdale Wound Management Guide

Comprehensive pocket handbook offers differential diagnosis and treatment options at your fingertips

Malvern, PA (June 8, 2009) – Proper wound care management has become one of the top concerns for many clinicians across various medical specialties. Treatment is specific to the wound type, the patient and the long-term care plan and requires ongoing assessment. Read More

2009 WOUNDS Article Index

Digital Edition

Today's Wound Clinic

Interactive BONUS content delivered to your email

CLICK HERE TO CONTINUE »

Issue

  • Issue: 
    8

    Aeromonas hydrophila bacterium is found in all freshwater environments as well as brackish, chlorinated, and unchlorinated water.1 The bacterium is both a gram-negative rod and a facultative anaerobe. The bacterium is about 0.3–1.0 µm in diameter and 1.0–3.5 µm in length. It achieves optimal growth at 28ºC (82ºF), but can also grow at temperatures ranging from 4C (39ºF) to 37ºC (99ºF).2,3 The bacterium was originally discovered in 1962 while researchers were

  • Issue: 
    8

    Since its introduction, vacuum-assisted closure (V.A.C.® Therapy, KCI, San Antonio,Tex) therapy has proven to be an adequate and noninvasive method in the treatment of complicated wounds.1,2 Vacuumassisted closure can be used in the treatment of many types of chronic wounds, such as venous stasis ulcers, pressure ulcers, dehisced surgical wounds, arterial and diabetic ulcers, and a wide variety of miscellaneous, long-existing wounds.3–5 Although complications related to its use are rare; localized superficial skin irritation is th

  • Issue: 
    8

    EUROPEAN WOUND CARE MARKET PROJECTS EXPONENTIAL GROWTH

    According to an analysis by Frost & Sullivan (London, England), the $1.1 billion European wound care market is slated to grow an annual average of 10%–12% from 2003 through 2009. This growth is expected as a result of traditional dressing and advanced wound care dressing markets. Growth in the advanced dressing market is projected to outstrip that of the traditional market, powering overall revenues to an estimated $2 billion by 2009.

  • Issue: 
    8

    Smith & Nephew Introduces Postoperative Antimicrobial Barrier Dressing

     

    Smith & Nephew Wound Management (Largo, Fla) introduces ACTICOAT® Post-Op, a new silvercoated antimicrobial barrier dressing designed to help manage infection risk following cardiothoracic, orthopedic, soft tissue, and other surgical procedures.
    ACTICOAT Post-Op is a tri-laminate dressing consisting of a proprietary perforated nanocrystalline silver (SILCRYST) wound contact layer, absorbent hydrocellular foam layer, and a transparent waterproof adhesive

  • Issue: 
    8

    Dear Readers,

    Have you treated a patient with a diabetic foot ulcer and a neuropathic (Charcot) foot lately? If you have, you are already aware of how complicated and difficult it is to treat them. Many eminent surgeons will recommend primary amputation with no thought given to treating the ulcer. British surgeon Sir Astley Cooper said, “He is a good surgeon who can amputate a limb, but he is a better surgeon who can save a limb.” This is a philosophy to which we all should adhere.
    Two of my wound care heroes, Dr. Grace Warren and Dr. Paul Brand, spent their entir

  • Issue: 
    8


    Dear Readers:

    Managing wound infection requires quick, accurate action. After a clinician diagnoses signs of infection in a wound,1 invading microorganisms are sampled, cultured and identified along with antibiotic(s) to which they are sensitive. Then an appropriate antibiotic is prescribed and administered to quell the infection. Research has identified valid, reliable diagnostic clinical signs and symptoms of infection in chronic wounds despite ambiguity

  • Issue: 
    8

    The human amniotic membrane has been used as a biological dressing for skin burns,wounds, and chronic leg ulcers. Its therapeutic effects have been attributed to its ability to promote epithelialization, inhibit fibrosis, and act as an antimicrobial agent.1 Human amniotic membrane products currently on the market, including Amniograft® and Prokera (Bio- Tissue Inc, Miami, Fla), are frozen with intact cellular structure, associated growth factors, and cytokines. ACELAGRAFT (Celgene Cellular Therapeutics, Cedar Knolls, NJ) is disti

  • Issue: 
    8

    Surgical infections (SIs) are infections of the tissues, organs or spaces, exposed by surgeons during performance of an invasive procedure. The development of SIs is related to 3 factors; the degree of microbial contamination of the wound during surgery, the duration of the procedure and host factors, such as diabetes, malnutrition, obesity, immunosuppression, and the number of other underlying disease states.1
    SIs are associated with considerable morbidity and occasional lethality, as well as substantial healthcare costs and patient inconvenience and dissatisfaction.2



WOUNDS Monthly Poll

Ostomy Wound Management

CLINICAL EVENTS CALENDAR

REVIEW OUR OTHER
WOUND CARE BRANDS

Check out our other resources for healthcare professionals of all specialties.

  • Ostomy Wound Management
  • Todays Wound Clinic
  • Podiatry Today
  • Skin and Aging

Web Analytics